Robert Byington's research topics

Robert Byington

Concepts (112)

Back to Profile

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name	Number of Publications	Most Recent Publication	Publications by All Authors	Concept Score	Why?
Diabetes Mellitus, Type 2	16	2017	1523	0.950	Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors	7	2017	168	0.800	Why?
Cardiovascular Diseases	11	2017	1209	0.700	Why?
Hypoglycemic Agents	6	2013	200	0.410	Why?
Simvastatin	2	2013	28	0.340	Why?
Diabetic Angiopathies	5	2013	153	0.320	Why?
Pravastatin	3	2004	16	0.310	Why?
Coronary Disease	3	2007	239	0.290	Why?
Randomized Controlled Trials as Topic	11	2010	565	0.280	Why?
Antihypertensive Agents	5	2015	378	0.240	Why?
Diabetes Mellitus, Type 1	1	2008	274	0.240	Why?
Heart Diseases	2	2008	124	0.240	Why?
Stroke	5	2011	700	0.230	Why?
Blood Pressure	3	2015	901	0.190	Why?
Progestins	1	2002	27	0.190	Why?
Middle Aged	17	2017	12703	0.180	Why?
Aged	16	2017	10998	0.180	Why?
Carotid Artery Diseases	1	2002	129	0.180	Why?
Estrogens	1	2002	210	0.170	Why?
Follow-Up Studies	7	2017	2366	0.170	Why?
Postmenopause	1	2002	461	0.160	Why?
Drug Therapy, Combination	5	2017	318	0.160	Why?
Female	18	2017	21490	0.150	Why?
Dyslipidemias	2	2017	61	0.150	Why?
Humans	24	2017	34474	0.140	Why?
Male	16	2017	20697	0.140	Why?
Triglycerides	2	2010	249	0.140	Why?
Hypertension	5	2015	1024	0.130	Why?
Risk Factors	10	2017	4136	0.130	Why?
Proportional Hazards Models	5	2011	803	0.130	Why?
Angiotensin II Type 1 Receptor Blockers	1	2007	70	0.130	Why?
Angiotensin-Converting Enzyme Inhibitors	1	2007	138	0.120	Why?
Hypoglycemia	3	2013	45	0.120	Why?
Renin-Angiotensin System	1	2007	178	0.120	Why?
Lipids	1	2017	267	0.120	Why?
Double-Blind Method	5	2017	597	0.120	Why?
Treatment Outcome	7	2017	3618	0.110	Why?
Treatment Failure	3	2010	170	0.110	Why?
Fibroblast Growth Factors	1	2014	36	0.110	Why?
Hypertrophy, Left Ventricular	1	2015	124	0.110	Why?
Thiazolidinediones	1	2013	51	0.100	Why?
Cholesterol, HDL	1	2013	194	0.100	Why?
Diabetic Nephropathies	1	2014	228	0.100	Why?
Anticholesteremic Agents	2	2004	47	0.090	Why?
Myocardial Infarction	3	2011	515	0.090	Why?
Renal Insufficiency, Chronic	1	2014	302	0.090	Why?
Multicenter Studies as Topic	2	2009	120	0.090	Why?
Coronary Artery Disease	2	2007	441	0.090	Why?
Sex Factors	2	2010	707	0.080	Why?
Blood Glucose	5	2013	529	0.080	Why?
Patient Selection	2	2009	291	0.080	Why?
Research Design	2	2009	337	0.080	Why?
Lipid Metabolism	2	2013	113	0.080	Why?
Incidence	3	2014	1288	0.070	Why?
Cholesterol	1	2010	273	0.070	Why?
Prospective Studies	4	2014	2461	0.070	Why?
Cerebrovascular Disorders	1	2008	55	0.070	Why?
Cohort Studies	2	2009	1910	0.060	Why?
Adult	6	2013	10015	0.060	Why?
Cholesterol, LDL	1	2008	185	0.060	Why?
Disease Progression	2	2014	633	0.060	Why?
Aspirin	1	2004	65	0.050	Why?
Maternal Mortality	1	2003	13	0.050	Why?
Platelet Aggregation Inhibitors	1	2004	94	0.050	Why?
Age Factors	3	2013	1261	0.050	Why?
Prenatal Care	1	2003	55	0.050	Why?
Tunica Media	1	2002	41	0.050	Why?
Amlodipine	1	2002	15	0.050	Why?
Tunica Intima	1	2002	81	0.050	Why?
Calcium Channel Blockers	1	2002	54	0.050	Why?
Glomerular Filtration Rate	2	2014	315	0.040	Why?
Estrogen Replacement Therapy	1	2002	222	0.040	Why?
Time Factors	2	2017	2352	0.040	Why?
Multivariate Analysis	3	2010	703	0.040	Why?
Case-Control Studies	2	2014	924	0.030	Why?
Sensitivity and Specificity	1	2007	612	0.030	Why?
Retrospective Studies	2	2017	3812	0.030	Why?
Dose-Response Relationship, Drug	1	2017	755	0.030	Why?
Canada	1	2014	69	0.030	Why?
Risk Assessment	2	2014	1506	0.030	Why?
Up-Regulation	1	2014	202	0.030	Why?
Kidney	1	2014	528	0.020	Why?
Hypokalemia	1	2010	16	0.020	Why?
Hyperglycemia	1	2010	88	0.020	Why?
Creatinine	1	2010	206	0.020	Why?
Cause of Death	1	2010	245	0.020	Why?
Hyperlipidemias	1	2010	61	0.020	Why?
Feasibility Studies	1	2009	323	0.020	Why?
Harm Reduction	1	2008	16	0.020	Why?
Continental Population Groups	1	2009	245	0.020	Why?
Body Weight	1	2009	343	0.020	Why?
Life Style	1	2009	418	0.020	Why?
Ethnic Groups	1	2009	483	0.020	Why?
United States	1	2014	4267	0.010	Why?
Prognosis	1	2008	1603	0.010	Why?
Regression Analysis	1	2003	310	0.010	Why?
Reproducibility of Results	1	2005	819	0.010	Why?
Coronary Restenosis	1	2002	15	0.010	Why?
Time	1	2002	29	0.010	Why?
Cesarean Section	1	2003	122	0.010	Why?
Odds Ratio	1	2003	480	0.010	Why?
Muscular Diseases	1	2002	25	0.010	Why?
Demography	1	2002	112	0.010	Why?
Gastrointestinal Diseases	1	2002	51	0.010	Why?
Renal Insufficiency	1	2002	58	0.010	Why?
Liver Diseases	1	2002	75	0.010	Why?
Coronary Angiography	1	2002	168	0.010	Why?
Hypercholesterolemia	1	2002	74	0.010	Why?
Risk	1	2002	325	0.010	Why?
Comorbidity	1	2002	596	0.010	Why?
North Carolina	1	2003	1612	0.010	Why?
Breast Neoplasms	1	2002	803	0.010	Why?

Byington's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (112)

Explore

Co-Authors (9)

Explore

Same Department

Explore

Physical Neighbors

Sisson, Caroline